CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries; oil hits $100
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits new 40-year high versus yen, euro softer after ECB stands pat on rates
Cytosorbents (CTSO) Misses Q1 EPS by 1c
May 14, 2025 4:03 PM EDTCytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $10.82 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More